Sessile Serrated Polyp Follow-Up
For sessile serrated polyps (SSPs) ≥10 mm or any serrated polyp with dysplasia (including traditional serrated adenomas), surveillance colonoscopy should be performed at 3 years; for SSPs <10 mm without dysplasia, no surveillance is needed and patients should return to routine screening. 1
Risk-Stratified Surveillance Algorithm
The 2020 US Multi-Society Task Force provides the most recent and comprehensive guidance, stratifying surveillance based on polyp size and dysplasia 1:
High-Risk SSPs: 3-Year Surveillance
- SSP ≥10 mm in size
- Any SSP with dysplasia
- Traditional serrated adenoma (any size)
These features indicate higher malignant potential, as larger SSPs are associated with increased risk of synchronous and metachronous advanced neoplasia 2.
Low-Risk SSPs: Return to Routine Screening (10 Years)
- 1-2 SSPs <10 mm without dysplasia
- No surveillance colonoscopy needed
- Return to standard screening intervals (10 years if organized screening available) 1
The British Society of Gastroenterology similarly recommends no surveillance for small SSPs without dysplasia unless they meet criteria for serrated polyposis syndrome 2.
Multiple SSPs: Modified Intervals
- 3-4 SSPs <10 mm: Consider 3-5 year interval 1
- If meeting WHO criteria for serrated polyposis syndrome: 1-2 yearly surveillance 2
Special Circumstances
Piecemeal Resection of Large SSPs
For SSPs ≥20 mm removed by piecemeal endoscopic mucosal resection:
- Site check at 2-6 months post-resection 2
- Then proceed to standard 3-year surveillance if no residual disease
- Recurrence rate is approximately 7% at 12 months for SSPs ≥20 mm 2
Combined Adenomas and SSPs
When both adenomas and serrated polyps are present, use the shortest recommended surveillance interval from either category 2. The risks are not considered cumulative, but each polyp type should be evaluated separately, with the higher-risk finding determining the interval.
Important Clinical Caveats
Pathologic variability is substantial. Distinguishing SSPs from hyperplastic polyps has significant interobserver variability, even among expert pathologists 3, 4. This diagnostic uncertainty is a major limitation in applying surveillance guidelines, as the 2020 recommendations acknowledge they are based on low-quality evidence 1.
Location matters. Proximal (right-sided) SSPs carry higher risk than distal lesions and are more challenging to detect endoscopically 2. Ensure adequate bowel preparation and withdrawal time to optimize detection.
Quality of baseline colonoscopy is critical. All surveillance recommendations assume high-quality baseline colonoscopy with complete cecal intubation, adequate visualization (ability to detect polyps >5 mm), adequate adenoma detection rate, and complete polyp resection 1. If these criteria are not met, earlier surveillance may be warranted.
Underuse of surveillance is common. Studies show 62% of patients with high-risk polyps demonstrate delayed or absent surveillance 5, particularly among older patients and those with lower income. Active tracking systems may be needed to ensure appropriate follow-up.
Divergence from European Guidelines
The 2020 ESGE guidelines differ slightly, recommending no surveillance for any serrated polyp <10 mm without dysplasia, regardless of number (1-4 polyps), with return to routine screening 6, 7. However, for SSPs ≥10 mm or with dysplasia, both US and European guidelines align on 3-year surveillance 6, 7. In practice, 90% of patients receive identical recommendations under either guideline system 8.
The US approach is more conservative for multiple small SSPs (3-4 polyps), recommending 3-5 year intervals rather than return to screening 1. Given the low quality of evidence and potential for rapid neoplasia development in serrated pathways 9, the more conservative US approach is prudent in clinical practice.